$ANGO
ANGIODYNAMICS INC Stock $ango

$ango Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000119312514137100 Filed on April 09, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$94.06M	$86.60M	$88.15M
YoY Change	0.0%	-1.76%	70.93%
Cost Of Revenue	$46.65M	$43.36M	$40.37M
YoY Change	1.06%	7.4%	82.26%
Gross Profit	$47.41M	$37.85M	$44.79M
YoY Change	0.0%	-15.5%	52.31%
Gross Profit Margin	50.4%	43.71%	50.81%
Selling, General & Admin	$31.80M	$27.15M	$24.57M
YoY Change	15.05%	10.5%	21.37%
% of Gross Profit	67.07%	71.72%	54.84%
Research & Development	$7.370M	$7.045M	$5.793M
YoY Change	14.44%	21.61%	26.76%
% of Gross Profit	15.55%	18.61%	12.93%
Depreciation & Amortization	$7.050M	$7.240M	$6.410M
YoY Change	-18.59%	12.95%	100.94%
% of Gross Profit	14.87%	19.13%	14.31%
Operating Expenses	$43.83M	$38.28M	$41.14M
YoY Change	11.01%	-6.96%	51.65%
Operating Profit	$3.584M	$6.513M	$58.00K
YoY Change	-54.8%	11129.31%	-97.46%
Interest Expense	-$530.0K	$917.0K	$1.271M
YoY Change	-58.91%	-27.85%	535.5%
% of Operating Profit	-14.79%	14.08%	2191.38%
Other Income/Expense, Net	-$1.474M	-$1.970M	-$1.879M
YoY Change	67.5%	4.84%	469.39%
Pretax Income	$2.110M	$4.543M	-$1.821M
YoY Change	-221.26%	-349.48%	-36.77%
Income Tax	$3.325M	$28.00K	-$829.0K
% Of Pretax Income	157.58%	0.62%
Net Earnings	-$1.215M	-$4.262M	$4.515M
YoY Change	0.0%	-194.4%	-355.08%
Net Earnings / Revenue	-1.29%	-4.92%	5.12%
Basic Earnings Per Share	-$0.03	-$0.12	$0.13
Diluted Earnings Per Share	-$0.03	-$0.12	$0.13
COMMON SHARES
Basic Shares Outstanding	35.42M shares	35.18M shares	34.83M shares
Diluted Shares Outstanding		35.70M shares	34.83M shares

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.20M	$15.62M	$18.80M
YoY Change	10.64%	-16.94%	-86.85%
Cash & Equivalents	$18.39M	$13.81M	$16.63M
Short-Term Investments	$1.809M	$1.807M	$2.200M
Other Short-Term Assets	$10.60M	$13.40M	$20.60M
YoY Change	-27.89%	-34.95%	56.06%
Inventory	$61.74M	$59.12M	$62.00M
Prepaid Expenses
Receivables	$61.97M	$57.73M	$45.10M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$147.0M	$140.1M	$146.4M
YoY Change	4.15%	-4.28%	-30.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.46M	$66.48M	$61.20M
YoY Change	6.54%	8.62%	164.94%
Goodwill	$360.5M	$359.7M
YoY Change	1.36%
Intangibles	$205.1M	$208.0M
YoY Change	-4.41%
Long-Term Investments
YoY Change
Other Assets	$3.806M	$5.592M	$12.90M
YoY Change	-22.45%	-56.65%	44.94%
Total Long-Term Assets	$651.6M	$652.0M	$650.1M
YoY Change	0.33%	0.3%	175.93%
TOTAL ASSETS
Total Short-Term Assets	$147.0M	$140.1M	$146.4M
Total Long-Term Assets	$651.6M	$652.0M	$650.1M
Total Assets	$798.6M	$792.2M	$796.5M
YoY Change	1.01%	-0.54%	78.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$32.90M	$25.51M	$23.70M
YoY Change	34.43%	7.62%	43.64%
Accrued Expenses	$15.94M	$18.97M	$19.70M
YoY Change	-0.13%	-3.73%	58.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.000M	$5.000M	$7.500M
YoY Change	-33.33%	-33.33%	2400.0%
Total Short-Term Liabilities	$65.94M	$63.38M	$66.80M
YoY Change	4.8%	-5.12%	128.77%
LONG-TERM LIABILITIES
Long-Term Debt	$137.7M	$133.9M	$136.9M
YoY Change	1.97%	-2.19%	2144.26%
Other Long-Term Liabilities	$531.0K	$188.0K	$65.40M
YoY Change	11.79%	-99.71%
Total Long-Term Liabilities	$138.2M	$188.0K	$202.3M
YoY Change	2.0%	-99.91%	3216.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.94M	$63.38M	$66.80M
Total Long-Term Liabilities	$138.2M	$188.0K	$202.3M
Total Liabilities	$261.7M	$254.5M	$269.1M
YoY Change	-0.96%	-5.43%	664.49%
SHAREHOLDERS EQUITY
Retained Earnings	$30.96M	$34.15M
YoY Change	8.2%
Common Stock	$508.7M	$507.0M
YoY Change	1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.104M	$2.104M
YoY Change	0.0%
Treasury Stock Shares	142.3K shares	142.3K shares
Shareholders Equity	$536.9M	$537.7M	$527.4M
YoY Change
Total Liabilities & Shareholders Equity	$798.6M	$792.2M	$796.5M
YoY Change	1.01%	-0.54%	78.35%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$1.215M	-$4.262M	$4.515M
YoY Change	0.0%	-194.4%	-355.08%
Depreciation, Depletion And Amortization	$7.050M	$7.240M	$6.410M
YoY Change	-18.59%	12.95%	100.94%
Cash From Operating Activities	$9.510M	-$590.0K	$10.00M
YoY Change	-14.56%	-105.9%	47.28%
INVESTING ACTIVITIES
Capital Expenditures	-$3.430M	-$1.840M	-$3.570M
YoY Change	-24.78%	-48.46%	170.45%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$30.00K	-$7.820M
YoY Change	-100.0%	-100.38%	-49.15%
Cash From Investing Activities	-$3.430M	-$1.810M	-$11.39M
YoY Change	-22.22%	-84.11%	-31.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.640M	-5.480M	-1.260M
YoY Change	-250.0%	334.92%	-227.27%
NET CHANGE
Cash From Operating Activities	9.510M	-590.0K	10.00M
Cash From Investing Activities	-3.430M	-1.810M	-11.39M
Cash From Financing Activities	2.640M	-5.480M	-1.260M
Net Change In Cash	8.720M	-7.880M	-2.650M
YoY Change	75.81%	197.36%	-70.29%
FREE CASH FLOW
Cash From Operating Activities	$9.510M	-$590.0K	$10.00M
Capital Expenditures	-$3.430M	-$1.840M	-$3.570M
Free Cash Flow	$12.94M	$1.250M	$13.57M
YoY Change	-17.53%	-90.79%	67.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35416167	shares
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23508000
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35060351	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35060351	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2013Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	142305	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1602000
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16426000
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3156000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	24522000
CY2013Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	135000000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	63437000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1534000
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6491000
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	75049000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	475000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	526830000
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	500554000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1272000
CY2013Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2034000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29563000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1573000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	61889000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	351000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	791584000
CY2013Q2	us-gaap	Liabilities Liabilities	264754000
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5782000
CY2013Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1047000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7500000
CY2013Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	276737000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	141516000
CY2013Q2	us-gaap	Goodwill Goodwill	355458000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	214848000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5559000
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2153000
CY2013Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	11006000
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	11007000
CY2013Q2	us-gaap	Assets Assets	791584000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21802000
CY2013Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	18362000
CY2013Q2	us-gaap	Prepaid Taxes PrepaidTaxes	563000
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47791000
CY2013Q2	us-gaap	Inventory Net InventoryNet	55062000
CY2013Q2	us-gaap	Prepaid Royalties PrepaidRoyalties	546000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7554000
CY2013Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2153000
CY2013Q2	us-gaap	Availableforsale Securities Failed Auction Value AvailableforsaleSecuritiesFailedAuctionValue	1850000
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1850000
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	6591000
CY2013Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2104000
CY2013Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25694000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62650000
CY2013Q2	ango	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
CY2013Q2	ango	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
CY2013Q2	ango	Interest Rate Swap Liability Current InterestRateSwapLiabilityCurrent	523000
CY2013Q2	ango	Number Of Investments Failed At Auction NumberOfInvestmentsFailedAtAuction	2	Investment
CY2013Q2	ango	Business Acquisition Contingent Consideration At Fair Value Current One BusinessAcquisitionContingentConsiderationAtFairValueCurrentOne	9207000
CY2013Q2	ango	Business Acquisition Contingent Consideration At Fair Value Noncurrent One BusinessAcquisitionContingentConsiderationAtFairValueNoncurrentOne	65842000
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16625000
CY2014Q1	invest	Derivative Notional Amount DerivativeNotionalAmount	100000000
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35416043	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35416043	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.0074	pure
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	142305	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2014Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1491000
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18966000
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4511000
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	25506000
CY2014Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	92500000
CY2014Q1	us-gaap	Deferred Income Taxes And Other Liabilities Noncurrent DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent	1166000
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	63380000
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1344000
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7529000
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	67987000
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188000
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	537689000
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	506638000
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1553000
CY2014Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	41410000
CY2014Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2279000
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34146000
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1471000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	74816000
CY2014Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	879000
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	353000
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	792174000
CY2014Q1	us-gaap	Liabilities Liabilities	254485000
CY2014Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	883000
CY2014Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1091000
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5000000
CY2014Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	282786000
CY2014Q1	us-gaap	Assets Current AssetsCurrent	140131000
CY2014Q1	us-gaap	Goodwill Goodwill	359736000
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	207970000
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5592000
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1807000
CY2014Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	13353000
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	11721000
CY2014Q1	us-gaap	Assets Assets	792174000
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7382000
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	23319000
CY2014Q1	us-gaap	Prepaid Taxes PrepaidTaxes	2727000
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57726000
CY2014Q1	us-gaap	Inventory Net InventoryNet	59834000
CY2014Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	546000
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6999000
CY2014Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1825000
CY2014Q1	us-gaap	Availableforsale Securities Failed Auction Value AvailableforsaleSecuritiesFailedAuctionValue	1800000
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1807000
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	3656000
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2104000
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	23162000
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66478000
CY2014Q1	ango	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	18000
CY2014Q1	ango	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
CY2014Q1	ango	Contingent Consideration At Remeasurement Date ContingentConsiderationAtRemeasurementDate	55800000
CY2014Q1	ango	Interest Rate Swap Liability Current InterestRateSwapLiabilityCurrent	594000
CY2014Q1	ango	Number Of Investments Failed At Auction NumberOfInvestmentsFailedAtAuction	2	Investment
CY2014Q1	ango	Noncurrent Portion Contingent Milestone Payments Fair Value Disclosure NoncurrentPortionContingentMilestonePaymentsFairValueDisclosure	12200000
CY2014Q1	ango	Business Acquisition Contingent Consideration At Fair Value Current One BusinessAcquisitionContingentConsiderationAtFairValueCurrentOne	12146000
CY2014Q1	ango	Business Acquisition Contingent Consideration At Fair Value Noncurrent One BusinessAcquisitionContingentConsiderationAtFairValueNoncurrentOne	55841000
CY2014Q1	ango	Undiscounted Contingent Consideration Disclosure UndiscountedContingentConsiderationDisclosure	80100000
CY2013Q4	ango	Ebitda Exit Multiple EbitdaExitMultiple	7.0	pure
CY2013Q4	ango	Percentage Of Fair Value Exceeding Its Carrying Value PercentageOfFairValueExceedingItsCarryingValue	0.06	pure
CY2013Q4	us-gaap	Restructuring Charges RestructuringCharges	4700000
CY2013Q4	us-gaap	Business Development BusinessDevelopment	5400000
CY2013Q4	ango	Business Development Program Period BusinessDevelopmentProgramPeriod	P3Y
CY2012Q3	ango	Number Of Observations NumberOfObservations	5	Observations
CY2013Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2013Q4	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.120	pure
CY2013Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Reporting_Unit
CY2013Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35315000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	528000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.703	pure
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	15515000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34787000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2900000	shares
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-398000
	us-gaap	Gross Profit GrossProfit	124747000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-721000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-99000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5134000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-34000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	650000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5707000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5625000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	103000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	422000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-211000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-119000
	us-gaap	Operating Income Loss OperatingIncomeLoss	5864000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	184000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-801000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	801000
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	24624000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	157000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3927000
	us-gaap	Net Income Loss NetIncomeLoss	256000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9468000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-467000
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-871000
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	129000
	us-gaap	Sales Revenue Net SalesRevenueNet	251994000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7708000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1096000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10134000
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	1878000
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1824000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19854000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	127247000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-4529000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3419000
	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-3000
	us-gaap	Share Based Compensation ShareBasedCompensation	3372000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18571000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6883000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	55734000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-17826000
	us-gaap	Interest Expense InterestExpense	3986000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19881000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11961000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16989000
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-254000
	us-gaap	Operating Expenses OperatingExpenses	118883000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-43000
	ango	Amortization Of Acquired Inventory Basis Step Up AmortizationOfAcquiredInventoryBasisStepUp	3845000
	ango	Loss On Discontinuance Of Product Offering LossOnDiscontinuanceOfProductOffering	1576000
	ango	Proceeds From Escrow Receivable ProceedsFromEscrowReceivable	2500000
	ango	Noncash Or Part Noncash Acquisition Intangible Assets And Business Acquired NoncashOrPartNoncashAcquisitionIntangibleAssetsAndBusinessAcquired	78286000
	ango	Acquisition Restructuring And Other Items Net AcquisitionRestructuringAndOtherItemsNet	9943000
	ango	Income Tax Reconciliation Nondeductible Expenses Acquisition Cost IncomeTaxReconciliationNondeductibleExpensesAcquisitionCost	102000
	ango	Income Tax Reconciliation Fully Reserved Capital Losses IncomeTaxReconciliationFullyReservedCapitalLosses	-179000
	ango	Income Tax Reconciliation Of Expense Benefit At Projected Tax Rates IncomeTaxReconciliationOfExpenseBenefitAtProjectedTaxRates	110000
	ango	Medical Device Excise Tax MedicalDeviceExciseTax	683000
	ango	Change In Fair Value Of Contingent Consideration One ChangeInFairValueOfContingentConsiderationOne	827000
	dei	Trading Symbol TradingSymbol	ANGO
	dei	Entity Registrant Name EntityRegistrantName	ANGIODYNAMICS INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-02-28
	dei	Entity Central Index Key EntityCentralIndexKey	0001275187
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35372000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	284000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.457	pure
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	15174000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35088000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2300000	shares
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	944000
	us-gaap	Gross Profit GrossProfit	133047000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	157000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	25000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	246000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	180000
	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	2285000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5579000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	145000000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	850000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	677000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	146000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4773000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	50000
	us-gaap	Operating Income Loss OperatingIncomeLoss	10430000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-18000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	-9551000
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	4169000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4851000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9693000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	18000
	us-gaap	Net Income Loss NetIncomeLoss	4583000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4225000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	190000
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-71000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1359000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4022000
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	-146000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
	us-gaap	Sales Revenue Net SalesRevenueNet	260390000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4994000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9003000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2208000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2699000
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	1200000
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2457000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19082000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	127343000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-16656000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2219000
	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	170000
	us-gaap	Share Based Compensation ShareBasedCompensation	4022000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	281000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18759000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-14420000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61736000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13024000
	us-gaap	Interest Expense InterestExpense	3122000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20757000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	41410000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	100000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12871000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-25000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	353000
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-33000
	us-gaap	Operating Expenses OperatingExpenses	122617000
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	123000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	86000
	ango	Payment Of Contingent Consideration PaymentOfContingentConsideration	14597000
	ango	Number Of Auction Rate Securities NumberOfAuctionRateSecurities	1	Securities
	ango	Amortization Of Acquired Inventory Basis Step Up AmortizationOfAcquiredInventoryBasisStepUp	150000
	ango	Noncash Or Part Noncash Acquisition Intangible Assets And Business Acquired NoncashOrPartNoncashAcquisitionIntangibleAssetsAndBusinessAcquired	4970000
	ango	Acquisition Restructuring And Other Items Net AcquisitionRestructuringAndOtherItemsNet	7697000
	ango	Costs For Quality Call To Action Program CostsForQualityCallToActionProgram	3200000
	ango	Income Tax Reconciliation Fully Reserved Capital Losses IncomeTaxReconciliationFullyReservedCapitalLosses	43000
	ango	Income Tax Reconciliation Of Expense Benefit At Projected Tax Rates IncomeTaxReconciliationOfExpenseBenefitAtProjectedTaxRates	2217000
	ango	Medical Device Excise Tax MedicalDeviceExciseTax	2955000
	ango	Number Of Business Days To Provide Response NumberOfBusinessDaysToProvideResponse	P15D
	ango	Change In Fair Value Of Contingent Consideration One ChangeInFairValueOfContingentConsiderationOne	-2481000
	ango	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Expense Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetExpenseIncludedInEarnings
	ango	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Expense Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExpenseIncludedInEarnings	2513000
CY2012Q1	ango	Number Of Observations NumberOfObservations	12	Observations
CY2012Q1	ango	Number Of Observations NumberOfObservations	6	Observations
CY2012Q4	ango	Number Of Observations NumberOfObservations	0	Observations
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35704000	shares
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	520000	shares
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.457	pure
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35184000	shares
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2014Q1	us-gaap	Gross Profit GrossProfit	45635000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	220000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	106000
CY2014Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	2285000
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1985000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5286000
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7569000
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-18000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5584000
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	5108000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	178000
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	132000
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	88195000
CY2014Q1	us-gaap	Other Restructuring Costs OtherRestructuringCosts	100000
CY2014Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1068000
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6231000
CY2014Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1000000
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	42560000
CY2014Q1	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	156000
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20700000
CY2014Q1	us-gaap	Interest Expense InterestExpense	917000
CY2014Q1	us-gaap	Severance Costs1 SeveranceCosts1	600000
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7045000
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4248000
CY2014Q1	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	300000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	42000
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	38066000
CY2014Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	57000
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	476000
CY2014Q1	ango	Acquisition Restructuring And Other Items Net AcquisitionRestructuringAndOtherItemsNet	3016000
CY2014Q1	ango	Income Tax Reconciliation Changes In Projected Income IncomeTaxReconciliationChangesInProjectedIncome	-50000
CY2014Q1	ango	Income Tax Reconciliation Fully Reserved Capital Losses IncomeTaxReconciliationFullyReservedCapitalLosses	43000
CY2014Q1	ango	Income Tax Reconciliation Of Expense Benefit At Projected Tax Rates IncomeTaxReconciliationOfExpenseBenefitAtProjectedTaxRates	2555000
CY2014Q1	ango	Medical Device Excise Tax MedicalDeviceExciseTax	980000
CY2014Q1	ango	Change In Fair Value Of Contingent Consideration One ChangeInFairValueOfContingentConsiderationOne	-4154000
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34834000	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.703	pure
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34834000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2900000	shares
CY2013Q1	us-gaap	Gross Profit GrossProfit	41201000
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	58000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1821000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	30000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-157000
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1879000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1031000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-992000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-39000
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	187000
CY2013Q1	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	129000
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	81571000
CY2013Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	608000
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6046000
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	40370000
CY2013Q1	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-30000
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18520000
CY2013Q1	us-gaap	Interest Expense InterestExpense	1271000
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5793000
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4314000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	69000
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	41143000
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-829000
CY2013Q1	ango	Acquisition Restructuring And Other Items Net AcquisitionRestructuringAndOtherItemsNet	5157000
CY2013Q1	ango	Income Tax Reconciliation Nondeductible Expenses Acquisition Cost IncomeTaxReconciliationNondeductibleExpensesAcquisitionCost	9000
CY2013Q1	ango	Income Tax Reconciliation Changes In Projected Income IncomeTaxReconciliationChangesInProjectedIncome	601000
CY2013Q1	ango	Income Tax Reconciliation Of Expense Benefit At Projected Tax Rates IncomeTaxReconciliationOfExpenseBenefitAtProjectedTaxRates	-1280000
CY2013Q1	ango	Medical Device Excise Tax MedicalDeviceExciseTax	683000
CY2013Q1	ango	Change In Fair Value Of Contingent Consideration One ChangeInFairValueOfContingentConsiderationOne	630000

Files In Submission

Name	View Source	Status
0001193125-14-137100-index-headers.html	Edgar Link	pending
0001193125-14-137100-index.html	Edgar Link	pending
0001193125-14-137100.txt	Edgar Link	pending
0001193125-14-137100-xbrl.zip	Edgar Link	pending
ango-20140228.xml	Edgar Link	completed
ango-20140228.xsd	Edgar Link	pending
ango-20140228_cal.xml	Edgar Link	unprocessable
ango-20140228_def.xml	Edgar Link	unprocessable
ango-20140228_lab.xml	Edgar Link	unprocessable
ango-20140228_pre.xml	Edgar Link	unprocessable
d687110d10q.htm	Edgar Link	pending
d687110dex311.htm	Edgar Link	pending
d687110dex312.htm	Edgar Link	pending
d687110dex321.htm	Edgar Link	pending
d687110dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANGO
ANGIODYNAMICS INC Stock $ango

2014 Q2 Form 10-Q Financial Statement

#000119312514137100 Filed on April 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANGO ANGIODYNAMICS INC Stock $ango

2014 Q2 Form 10-Q Financial Statement

#000119312514137100 Filed on April 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANGO
ANGIODYNAMICS INC Stock $ango